Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.9690
+0.0090 (0.94%)
May 7, 2025, 1:53 PM EDT - Market open

Clearmind Medicine Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jan '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2017 - 2019
Selling, General & Admin
4.244.364.763.172.440.18
Upgrade
Research & Development
1.621.381.543.080.52-
Upgrade
Operating Expenses
5.865.746.36.252.970.31
Upgrade
Operating Income
-5.86-5.74-6.3-6.25-2.97-0.31
Upgrade
Interest Expense
-0.04-0.04-0.01-0.01--
Upgrade
Interest & Investment Income
0.240.270.09---
Upgrade
Currency Exchange Gain (Loss)
-0.01-0.01-0.08-0-0.03-
Upgrade
Other Non Operating Income (Expenses)
1.070.71-2.19-0.29--
Upgrade
EBT Excluding Unusual Items
-4.6-4.81-8.5-6.56-3-0.31
Upgrade
Gain (Loss) on Sale of Investments
-0.14-0.07-0.11-0.31--
Upgrade
Pretax Income
-4.74-4.88-8.6-6.87-3-0.31
Upgrade
Income Tax Expense
0.220.380.020.03--
Upgrade
Net Income
-4.96-5.25-8.62-6.89-3-0.31
Upgrade
Net Income to Common
-4.96-5.25-8.62-6.89-3-0.31
Upgrade
Shares Outstanding (Basic)
430000
Upgrade
Shares Outstanding (Diluted)
430000
Upgrade
Shares Change (YoY)
582.94%1431.07%367.25%40.19%70.50%47.00%
Upgrade
EPS (Basic)
-1.29-1.69-42.58-159.11-97.06-17.12
Upgrade
EPS (Diluted)
-1.29-1.69-42.58-159.11-97.06-17.12
Upgrade
Free Cash Flow
-4.66-4.86-6.3-3.73-2.31-0.21
Upgrade
Free Cash Flow Per Share
-1.21-1.57-31.12-86.08-74.84-11.38
Upgrade
EBITDA
-5.85-5.73-6.28-6.23-2.96-0.18
Upgrade
D&A For EBITDA
0.010.010.020.020.010.14
Upgrade
EBIT
-5.86-5.74-6.3-6.25-2.97-0.31
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q